Compare EQIX & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EQIX | MCK |
|---|---|---|
| Founded | 1998 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.1B | 115.8B |
| IPO Year | 2000 | 1995 |
| Metric | EQIX | MCK |
|---|---|---|
| Price | $1,061.74 | $1,060.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 35 | 16 |
| Target Price | ★ $1,234.88 | $1,129.07 |
| AVG Volume (30 Days) | 632.8K | ★ 698.2K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.04% | 0.35% |
| EPS Growth | ★ 61.88 | 49.22 |
| EPS | 13.96 | ★ 15.53 |
| Revenue | $5,998,545,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $11.78 | $7.05 |
| Revenue Next Year | $11.30 | $6.85 |
| P/E Ratio | $72.68 | ★ $68.50 |
| Revenue Growth | ★ 7.85 | 3.11 |
| 52 Week Low | $720.62 | $723.68 |
| 52 Week High | $1,128.68 | $1,121.50 |
| Indicator | EQIX | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 69.96 |
| Support Level | $1,046.20 | $835.39 |
| Resistance Level | $1,082.17 | N/A |
| Average True Range (ATR) | 36.49 | 26.24 |
| MACD | 7.10 | 4.71 |
| Stochastic Oscillator | 96.11 | 63.45 |
Equinix is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and businesses. Equinix operates 270 properties in 77 metropolitan areas across 36 countries, serving over 10,000 customers. About 70% of Equinix's revenue comes from renting physical space, which allows hyperscalers and other clients to store servers, data storage, and networking equipment. The other 30% of revenue is generated primarily through interconnection services (20%) and other managed services (10%).
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.